USITC.gov will be periodically unavailable between 5:30 p.m. and 8:30 p.m. ET on Wednesday, July 22, 2026, to conduct system maintenance. Please plan your activities accordingly.

Certain Pertuzumab Biosimilars, Including Those Made by Certain Methods of Manufacturing, the Active Ingredient Thereof, and Products Containing the Same

Friday, February 27, 2026 - 12:00

Docket Number

3890

Receipt of Complaint; Solicitation of Comments Relating to the Public Interest

Section 337 Notices

Notice/Action Title

Receipt of Complaint; Solicitation of Comments Relating to the Public Interest

Certain Pertuzumab Biosimilars, Including Those Made by Certain Methods of Manufacturing, the Active Ingredient Thereof (143.47 KB)

Pagewatch Key

USITC_151

Pagewatch Setting

Disabled

Certain Pertuzumab Biosimilars, Including Those Made by Certain Methods of Manufacturing, the Active Ingredient Thereof, and Products Containing the Same

Get USITC News in Your Inbox